Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophageal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07653451
What this trial is testing

Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 90
Early research (Phase 1)UnknownNCT04229537
What this trial is testing

Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC

Who this might be right for
Esophageal Squamous Cell CarcinomaColorectal Cancer
Sinocelltech Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00069953
What this trial is testing

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06508229
What this trial is testing

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Harbin Medical University 65
Early research (Phase 1)Looking for participantsNCT05865002
What this trial is testing

A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)

Who this might be right for
Relapsed Malignant Solid Neoplasm
Aurigene Discovery Technologies Limited 50
Large-scale testing (Phase 3)Study completedNCT00193882
What this trial is testing

Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.

Who this might be right for
Esophagus Cancer
Trans Tasman Radiation Oncology Group 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT06888531
What this trial is testing

Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Malignant Neoplasm Primary
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01747551
What this trial is testing

FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Dana-Farber Cancer Institute 64
Testing effectiveness (Phase 2)Study completedNCT02429622
What this trial is testing

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Neoplasms
Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)Study completedNCT00971841
What this trial is testing

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer

Who this might be right for
Esophageal Cancer
Bristol-Myers Squibb 1
Testing effectiveness (Phase 2)UnknownNCT03279601
What this trial is testing

Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor

Who this might be right for
Neuroendocrine Tumors
Peking University 148
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Testing effectiveness (Phase 2)Looking for participantsNCT06061146
What this trial is testing

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 136
Early research (Phase 1)Looking for participantsNCT03917043
What this trial is testing

APG-2449 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid CancerNon Small Cell Lung CancerEsophageal Cancer+2 more
Ascentage Pharma Group Inc. 165
Testing effectiveness (Phase 2)Active Not RecruitingNCT04494009
What this trial is testing

PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy

Who this might be right for
Esophageal Cancer
Asan Medical Center 110
Testing effectiveness (Phase 2)Looking for participantsNCT07437898
What this trial is testing

Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study

Who this might be right for
Esophageal Squamous Cell Carcinoma
The Affiliated Hospital of Putian University 42
Testing effectiveness (Phase 2)UnknownNCT05777707
What this trial is testing

Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma

Who this might be right for
Esophageal CarcinomaNeoadjuvant Immunotherapy
Beijing Friendship Hospital 89
Early research (Phase 1)Ended earlyNCT03449030
What this trial is testing

TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)

Who this might be right for
Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT02559687
What this trial is testing

Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 121
Large-scale testing (Phase 3)Looking for participantsNCT06907602
What this trial is testing

Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 120
Next Page